Self-Regulatory Organizations; Philadelphia Stock Exchange, Inc.; Notice of Filing and Immediate Effectiveness of Proposed Rule Change and Amendment No. 1 Thereto To Impose a New Licensing Fee in Connection With the Firm-Related Equity Option and Index Option Fee Cap, 42611-42613 [E5-3945]
Download as PDF
Federal Register / Vol. 70, No. 141 / Monday, July 25, 2005 / Notices
open market, and, in general, to protect
investors and the public interest.
A complex order sent to the PCX
currently routes to and resides on the
EOC until it trades in open outcry.
Thus, a complex order currently cannot
be executed on the PCX without manual
intervention by a Floor Broker.
The CTE will allow complex orders to
trade electronically, without the
intervention of a Floor Broker. OTP
Holders and OTP Firms will use an
electronic interface to the PCX to view
complex orders resting in the CTE. As
described more fully above, a complex
order routed to the CTE may execute
automatically against orders in the
Exchange’s consolidated book or against
an order resting in the CTE. In addition,
OTP Holders and OTP Firms may trade
against orders resting in the CTE.
Accordingly, the Commission believes
that the CTE should increase the
transparency of complex orders and
could facilitate the execution of
complex orders.
Under the proposal, the Exchange will
determine which options classes will
route directly to the CTE and those that
will route to the EOC. The Commission
notes that PCX Rule 6.76(c) applies to
complex orders on PCX Plus.15
Accordingly, an OTP Holder or OTP
Firm seeking to trade with its
customer’s complex order, or to cross
complex orders, would be required to
comply with PCX Rule 6.76(c).
In addition, the complex order
priority provisions in PCX Rule 6.75(e)
and PCX Rule 6.75, Commentary .04,
will continue to apply to complex
orders. Accordingly, complex orders
will be able to trade ahead of orders in
the consolidated book only under the
conditions specified in PCX Rule 6.75(e)
and PCX Rule 6.75, Commentary .04.
The Commission also notes that
complex orders from public customers
will have priority over complex orders
from non-public customers.16
The Commission finds good cause for
approving the proposed rule change
prior to the thirtieth day after the date
of publication of notice thereof in the
Federal Register. The Commission notes
that the proposal is similar to a Chicago
Board Options Exchange, Inc. (‘‘CBOE’’)
proposal that the Commission
approved.17 Accelerated approval of the
PCX’s proposal may help the PCX to
compete for complex orders.
Accordingly, the Commission finds
good cause, consistent with Sections
15 See
note 10, supra.
PCX Rule 6.76(a)(A).
17 See Securities Exchange Act Release No. 51271
(February 28, 2005), 70 FR 10712 (March 4, 2005)
(SR–CBOE–2004–45).
16 See
VerDate jul<14>2003
14:21 Jul 22, 2005
Jkt 205001
6(b)(5)and 19(b) of the Exchange Act, to
approve the proposed rule change, as
amended, on an accelerated basis.
IV. Conclusion
It is therefore ordered, pursuant to
Section 19(b)(2) of the Act,18 that the
proposed rule change (SR–PCX–2005–
71), as amended, is approved.
For the Commission, by the Division of
Market Regulation, pursuant to delegated
authority.19
Jill M. Peterson,
Assistant Secretary.
[FR Doc. E5–3946 Filed 7–22–05; 8:45 am]
BILLING CODE 8010–01–P
SECURITIES AND EXCHANGE
COMMISSION
[Release No. 34–52054; File No. SR–Phlx–
2005–40]
Self-Regulatory Organizations;
Philadelphia Stock Exchange, Inc.;
Notice of Filing and Immediate
Effectiveness of Proposed Rule
Change and Amendment No. 1 Thereto
To Impose a New Licensing Fee in
Connection With the Firm-Related
Equity Option and Index Option Fee
Cap
July 18, 2005.
Pursuant to Section 19(b)(1) of the
Securities Exchange Act of 1934
(‘‘Act’’),1 and Rule 19b–4 thereunder,2
notice is hereby given that on June 7,
2005, the Philadelphia Stock Exchange,
Inc. (‘‘Phlx’’ or ‘‘Exchange’’) filed with
the Securities and Exchange
Commission (‘‘Commission’’) the
proposed rule change as described in
Items I, II, and III below, which Items
have been prepared by the Exchange.
On July 5, 2005, the Exchange filed
Amendment No. 1 to the proposed rule
change.3 Phlx has designated this
proposal as one establishing or changing
a due, fee, or other charge imposed by
a self-regulatory organization pursuant
to Section 19(b)(3)(A) of the Act,4 and
U.S.C. 78s(b)(2).
CFR 200.30–3(a)(12).
1 15 U.S.C. 78s(b)(1).
2 17 CFR 240.19b–4.
3 In Amendment No. 1, the Exchange made nonsubstantive changes to re-format a defined term and
clarify the addition of disclaimer language in its
$60,000 ‘‘Firm Related’’ Equity Option and Index
Option Cap schedule. The effective date of the
original proposed rule change is June 7, 2005, and
the effective date of Amendment No. 1 is July 5,
2005. For purposes of calculating the 60-day period
within which the Commission may summarily
abrogate the proposed rule change, as amended,
under Section 19(b)(3)(C) of the Act, the
Commission considers such period to commence on
July 5, 2005, the date on which the Exchange filed
Amendment No. 1. See 15 U.S.C. 78s(b)(3)(C).
4 15 U.S.C. 78s(b)(3)(A).
PO 00000
18 15
19 17
Frm 00081
Fmt 4703
Sfmt 4703
42611
Rule 19b–4(f)(2) thereunder,5 which
renders the proposal effective upon
filing with the Commission. The
Commission is publishing this notice to
solicit comments on the proposed rule
change, as amended, from interested
persons.
I. Self-Regulatory Organization’s
Statement of the Terms of Substance of
the Proposed Rule Change
The Phlx proposes to amend its
schedule of fees to adopt a license fee
of $0.10 for options traded on the
following products: 6 (1) iShares S&P
100 Index, traded under the symbol
OEF; (2) iShares S&P Europe 350, traded
under the symbol IEV; (3) iShares S&P
Global 100 Index, traded under the
symbol IOO; (4) iShares S&P Global
Energy Sector Index, traded under the
symbol IXC; (5) iShares S&P Global
Financial Sector Index, traded under the
symbol IXG; (6) iShares S&P Global
Healthcare Sector Index, traded under
the symbol IXJ; (7) iShares S&P Global
Information Technology Sector Index,
traded under the symbol IXN; (8)
iShares S&P Global Telecom Sector
Index, traded under the symbol IXP; (9)
iShares S&P Latin America 40, traded
under the symbol ILF; (10) iShares S&P
MidCap 400, traded under the symbol
IJH; (11) iShares S&P SmallCap 600,
traded under the symbol IJR; (12)
iShares S&P TOPIX 150, traded under
the symbol ITF; (13) iShares S&P 500,
traded under the symbol IVV; (14) S&P
Industrial Select Sector SPDR, traded
under the symbol XLI; (15) S&P
Technology Select Sector SPDR, traded
under the symbol XLK; (16) S&P
Utilities Select Sector SPDR, traded
under the symbol XLU; (17) S&P
Consumer Staples Select Sector SPDR,
traded under the symbol XLP; (18) S&P
Energy Select Sector SPDR, traded
under the symbol XLE; (19) S&P
Financial Select Sector SPDR, traded
under the symbol XLF; (20) S&P Health
Care Select Sector SPDR, traded under
the symbol XLV; (21) S&P Materials
Select Sector SPDR, traded under the
symbol XLB; (22) S&P Consumer
Discretionary Select Sector SPDR,
traded under the symbol XLY; (23)
MidCap SPDR, traded under the symbol
MDY (collectively, the ‘‘S&P products’’);
and (24) WellSpring Bio-Clinical Trials
5 17
CFR 240.19b–4(f)(2).
Exchange represents that this fee will be
charged only to Exchange members. Telephone
conversation between Cynthia Hoekstra, Director,
Phlx, and Edward Cho, Attorney, Division of
Market Regulation (‘‘Division’’), Commission (July
7, 2005).
6 The
E:\FR\FM\25JYN1.SGM
25JYN1
42612
Federal Register / Vol. 70, No. 141 / Monday, July 25, 2005 / Notices
Index (‘‘WHC’’) 7 to be assessed per
contract side for equity option and
index option ‘‘firm’’ transactions
(comprised of equity option firm/
proprietary comparison transactions,
equity option firm/proprietary
transactions, equity option firm/
proprietary facilitation transactions,
index option firm/proprietary
comparison transactions, index option
firm/proprietary transactions and index
option firm/proprietary facilitation
transactions). This license fee will be
imposed only after the Exchange’s
$60,000 ‘‘firm-related’’ equity option
and index option comparison and
transaction charge cap, described more
fully below, is reached.
Currently, the Exchange imposes a
cap of $60,000 per member
organization 8 on all ‘‘firm-related’’
equity option and index option
comparison and transaction charges
combined.9 Specifically, ‘‘firm-related’’
charges include equity option firm/
proprietary comparison charges, equity
option firm/proprietary transaction
charges, equity option firm/proprietary
facilitation transaction charges, index
option firm/proprietary comparison
charges, index option firm/proprietary
transaction charges, and index option
firm/proprietary facilitation transaction
charges (collectively, the ‘‘firm-related
charges’’). Thus, such firm-related
charges in the aggregate for one billing
month may not exceed $60,000 per
month per member organization.
The Exchange also imposes a license
fee of $0.10 per contract side for equity
option ‘‘firm’’ transactions on options
on Nasdaq-100 Index Tracking
StockSM 10 traded under the symbol
7 WellSpring Bio-Clinical Trials Index,
‘‘ORCHIDs’’ and ‘‘WellSpring’’ are trademarks of
WellSpring BioCapital Partners, LLC (‘‘WellSpring
LLC’’) and have been licensed for use by the
Exchange. WellSpring LLC makes no
recommendations concerning the advisability of
investing in options based on the WellSpring BioClinical Trials Index.
8 The firm/proprietary comparison or transaction
charge applies to member organizations for orders
for the proprietary account of any member or nonmember broker-dealer that derives more than 35%
of its annual, gross revenues from commissions and
principal transactions with customers. Member
organizations are required to verify this amount to
the Exchange by certifying that they have reached
this threshold by submitting a copy of their annual
report, which was prepared in accordance with
Generally Accepted Accounting Principles
(‘‘GAAP’’). In the event that a member organization
has not been in business for one year, the most
recent quarterly reports, prepared in accordance
with GAAP, are accepted. See Securities Exchange
Act Release No. 43558 (November 14, 2000), 65 FR
69984 (November 21, 2000) (SR–Phlx–2000–85).
9 See Securities Exchange Act Release No. 51024
(January 11, 2005), 70 FR 3088 (January 19, 2005)
(SR–Phlx–2004–94).
10 The Nasdaq-100, Nasdaq-100 Index,
Nasdaq, The Nasdaq Stock Market, Nasdaq-100
VerDate jul<14>2003
14:21 Jul 22, 2005
Jkt 205001
QQQQ (‘‘QQQ’’) and certain other
licensed products (collectively, the
‘‘licensed products’’) 11 after the $60,000
cap, as described above, is reached.
Therefore, when a member organization
exceeds the $60,000 cap (comprised of
combined firm-related charges), the
member organization is charged
$60,000, plus license fees of $0.10 per
contract side for any contracts in
licensed products (if any) over those
that were included in reaching the
$60,000 cap. In other words, if the cap
is reached, the $0.10 license fee is
imposed on all subsequent equity
option and index option firm
transactions; these license fees are
charged in addition to the $60,000 cap.
The Exchange proposes to adopt a
$0.10 license fee per contract side for
the S&P products and WHC for equity
option and index option firm
transactions, which will be imposed
after the $60,000 cap is reached in the
same way as the current licensed
product fees are assessed. Thus, when a
member organization exceeds the
$60,000 cap, the member organization
will be charged $60,000 plus any
applicable license fees for trades of
licensed products, including the S&P
products and WHC, over those trades
that were counted in reaching the
$60,000 cap.12
SharesSM, Nasdaq-100 TrustSM, Nasdaq-100 Index
Tracking StockSM, and QQQSM are trademarks or
service marks of The Nasdaq Stock Market, Inc.
(‘‘Nasdaq’’) and have been licensed for use for
certain purposes by the Phlx pursuant to a License
Agreement with Nasdaq. The Nasdaq-100 Index
(the ‘‘Index’’) is determined, composed, and
calculated by Nasdaq without regard to the
Licensee, the Nasdaq-100 TrustSM, or the beneficial
owners of Nasdaq-100 SharesSM. Nasdaq has
complete control and sole discretion in
determining, comprising, or calculating the Index or
in modifying in any way its method for
determining, comprising, or calculating the Index in
the future.
11 In addition to the QQQs, the following licensed
products are assessed a $0.10 license fee per
contract side after the $60,000 cap is reached:
Russell 1000 Growth iShares (IWF); Russell 2000
iShares (IWM); Russell 2000 Value iShares (IWN);
Russell 2000 Growth iShares (IWO); Russell Midcap
Growth iShares (IWP); Russell Midcap Value
iShares (IWS); NYSE Composite Index (NYC); NYSE
U.S. 100 Index (NY); and Standard & Poor’s
Depositary Receipts, Trust Series 1 (SPY); iShares
Lehman 1–3 Year Treasury Bond Fund (SHY);
iShares Lehman 7–10 Year Treasury Bond Fund
(IEF); iShares Lehman 20+ Treasury Bond Fund
(TLT); iShares Lehman Aggregate Bond Fund
(AGG); iShares Lehman TIPS Bond Fund (TIP);
KBW Capital Markets Index (KSX); KBW Insurance
Index (KIX); and Phlx/KBW Bank Index (BKX).
12 Consistent with current practice, when
calculating the $60,000 cap, the Exchange first
calculates all equity option and index option
transaction and comparison charges for products
without license fees and then equity option and
index option transaction and comparison charges
for products with license fees (i.e., QQQ license
fees) that are assessed by the Exchange after the
$60,000 cap is reached. See Securities Exchange Act
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
In addition, the Exchange proposes to
make a technical change to its Summary
of Index Option and FXI Options
Charges (‘‘Options Charge Schedule’’) to
make a footnote, which relates to the
$60,000 cap and appears in other
applicable sections of the Exchange’s fee
schedule, more consistent.13 The
Exchange also proposes to include nonsubstantive disclaimer language relating
to the trading of certain licensed
products on the Exchange in its $60,000
‘‘Firm Related’’ Equity Option and
Index Option Cap schedule (‘‘$60,000
Cap Schedule’’).14 The fees set forth in
this proposal are scheduled to become
effective for transactions settling on or
after June 8, 2005.
The text of the proposed rule change
is available on the Phlx’s Internet Web
site (https://www.phlx.com), at the Phlx’s
Office of the Secretary, and at the
Commission’s Public Reference Room.
II. Self-Regulatory Organization’s
Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule
Change
In its filing with the Commission, the
Phlx included statements concerning
the purpose of and basis for the
proposed rule change and discussed any
comments it received on the proposal.
The text of these statements may be
examined at the places specified in Item
IV below. The Exchange has prepared
summaries, set forth in sections A, B,
and C below, of the most significant
aspects of such statements.
A. Self-Regulatory Organization’s
Statement of the Purpose of, and the
Statutory Basis for, the Proposed Rule
Change
1. Purpose
The purpose of assessing the S&P
products and WHC license fee of $0.10
per contract side after reaching the
$60,000 cap as described in this
proposal is to help defray licensing
costs associated with the trading of
these products, while still capping
member organizations’ fees enough to
attract volume from other exchanges.
The cap operates this way in order to
offer an incentive for additional volume
without leaving the Exchange with
significant out-of-pocket costs.
The purpose of making minor
technical changes to the Exchange’s
Options Charge Schedule is to make a
footnote, which relates to the $60,000
Release No. 50836 (December 10, 2004), 69 FR
75584 (December 17, 2004) (SR–Phlx–2004–70).
13 Telephone conversation between Cynthia
Hoekstra, Director, Phlx, and Edward Cho,
Attorney, Division, Commission (July 7, 2005).
14 Id.
E:\FR\FM\25JYN1.SGM
25JYN1
Federal Register / Vol. 70, No. 141 / Monday, July 25, 2005 / Notices
cap and appears in other applicable
sections of the Exchange’s fee schedule,
more consistent. In addition, the
Exchange proposes to include nonsubstantive disclaimer language relating
to the trading of certain licensed
products on the Exchange in its $60,000
Cap Schedule.
2. Statutory Basis
The Exchange believes that the
proposed rule change, as amended, is
consistent with Section 6(b) of the Act 15
in general, and furthers the objectives of
Section 6(b)(4) of the Act 16 in
particular, in that it is an equitable
allocation of reasonable dues, fees, and
other charges among Exchange
members.
B. Self-Regulatory Organization’s
Statement on Burden on Competition
The Phlx believes that the proposed
rule change would impose no burden on
competition that is not necessary or
appropriate in furtherance of the
purposes of the Act.
C. Self-Regulatory Organization’s
Statement on Comments on the
Proposed Rule Change Received From
Members, Participants or Others
The Exchange did not solicit or
receive any written comments with
respect to the proposal.
III. Date of Effectiveness of the
Proposed Rule Change and Timing for
Commission Action
The foregoing proposed rule change,
as amended, has been designated as a
fee change pursuant to Section
19(b)(3)(A)(ii) of the Act 17 and Rule
19b–4(f)(2) 18 thereunder. Accordingly,
the proposal is effective upon filing
with the Commission. At any time
within 60 days of the filing of the
amended proposed rule change, the
Commission may summarily abrogate
such rule change if it appears to the
Commission that such action is
necessary or appropriate in the public
interest, for the protection of investors,
or otherwise in furtherance of the
purposes of the Act.19
IV. Solicitation of Comments
Interested persons are invited to
submit written data, views, and
arguments concerning the foregoing,
including whether the proposed rule
change, as amended, is consistent with
the Act. Comments may be submitted by
any of the following methods:
Electronic Comments
DEPARTMENT OF STATE
• Use the Commission’s Internet
comment form (https://www.sec.gov/
rules/sro.shtml); or
• Send an e-mail to rulecomments@sec.gov. Please include File
Number SR–Phlx–2005–40 on the
subject line.
[Public Notice 5139]
For the Commission, by the Division of
Market Regulation, pursuant to delegated
authority.20
Jill M. Peterson,
Assistant Secretary.
[FR Doc. E5–3945 Filed 7–22–05; 8:45 am]
BILLING CODE 4710–08–P
BILLING CODE 8010–01–P
U.S.C. 78f(b).
U.S.C. 78f(b)(4).
17 15 U.S.C. 78s(b)(3)(A)(ii).
18 17 CFR 240.19b–4(f)(2).
19 See supra note 3.
16 15
14:21 Jul 22, 2005
20 17
Jkt 205001
Culturally Significant Objects Imported
for Exhibition; Determinations: ‘‘David
Milne Watercolors: Painting Toward
the Light’’
SUMMARY: Notice is hereby given of the
following determinations: Pursuant to
Paper Comments
the authority vested in me by the Act of
October 19, 1965 (79 Stat. 985; 22 U.S.C.
• Send paper comments in triplicate
2459), Executive Order 12047 of March
to Jonathan G. Katz, Secretary,
27, 1978, the Foreign Affairs Reform and
Securities and Exchange Commission,
Restructuring Act of 1998 (112 Stat.
Station Place, 100 F Street NE.,
2681, et seq.; 22 U.S.C. 6501 note, et
Washington, DC 20549–9303.
seq.), Delegation of Authority No. 234 of
October 1, 1999, and Delegation of
All submissions should refer to File
Authority No. 236 of October 19, 1999,
Number SR–Phlx–2005–40. This file
as amended, and Delegation of
number should be included on the
subject line if e-mail is used. To help the Authority No. 257 of April 15, 2003 [68
FR 19875], I hereby determine that the
Commission process and review your
objects to be included in the exhibition
comments more efficiently, please use
only one method. The Commission will ‘‘David Milne Watercolors: Painting
post all comments on the Commission’s Toward the Light,’’ imported from
abroad for temporary exhibition within
Internet Web site (https://www.sec.gov/
the United States, are of cultural
rules/sro.shtml). Copies of the
significance. The objects are imported
submission, all subsequent
pursuant to a loan agreement with the
amendments, all written statements
foreign lenders. I also determine that the
with respect to the proposed rule
exhibition or display of the exhibit
change that are filed with the
objects at The Metropolitan Museum of
Commission, and all written
Art, New York, NY from on or about
communications relating to the
November 7, 2005 to on or about
proposed rule change between the
January 29, 2006, and at possible
Commission and any person, other than additional venues yet to be determined,
those that may be withheld from the
is in the national interest. Public Notice
public in accordance with the
of these determinations is ordered to be
provisions of 5 U.S.C. 552, will be
published in the Federal Register.
available for inspection and copying in
FOR FURTHER INFORMATION CONTACT: For
the Commission’s Public Reference
further information, including a list of
Room. Copies of such filing also will be the exhibit objects, contact Carol B.
available for inspection and copying at
Epstein, Attorney-Adviser, Office of the
the principal office of the Exchange. All Legal Adviser, Department of State,
(telephone: (202) 453–8048). The
comments received will be posted
address is Department of State, SA–44,
without change; the Commission does
301 4th Street, SW., Room 700,
not edit personal identifying
Washington, DC 20547–0001.
information from submissions. You
should submit only information that
Dated: July 18, 2005.
you wish to make available publicly. All C. Miller Crouch,
submissions should refer to File
Principal Deputy Assistant Secretary for
Number SR–Phlx–2005–40 and should
Educational and Cultural Affairs Department
of State.
be submitted on or before August 15,
2005.
[FR Doc. 05–14611 Filed 7–22–05; 8:45 am]
15 15
VerDate jul<14>2003
42613
PO 00000
CFR 200.30–3(a)(12).
Frm 00083
Fmt 4703
Sfmt 4703
DEPARTMENT OF STATE
[Public Notice 5140]
Culturally Significant Objects Imported
for Exhibition Determinations:
‘‘Monumental Sculpture in Florence:
Ghiberti, Nanni di Banco, and
Verrocchio’’
SUMMARY: Notice is hereby given of the
following determinations: Pursuant to
E:\FR\FM\25JYN1.SGM
25JYN1
Agencies
[Federal Register Volume 70, Number 141 (Monday, July 25, 2005)]
[Notices]
[Pages 42611-42613]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E5-3945]
-----------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
[Release No. 34-52054; File No. SR-Phlx-2005-40]
Self-Regulatory Organizations; Philadelphia Stock Exchange, Inc.;
Notice of Filing and Immediate Effectiveness of Proposed Rule Change
and Amendment No. 1 Thereto To Impose a New Licensing Fee in Connection
With the Firm-Related Equity Option and Index Option Fee Cap
July 18, 2005.
Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(``Act''),\1\ and Rule 19b-4 thereunder,\2\ notice is hereby given that
on June 7, 2005, the Philadelphia Stock Exchange, Inc. (``Phlx'' or
``Exchange'') filed with the Securities and Exchange Commission
(``Commission'') the proposed rule change as described in Items I, II,
and III below, which Items have been prepared by the Exchange. On July
5, 2005, the Exchange filed Amendment No. 1 to the proposed rule
change.\3\ Phlx has designated this proposal as one establishing or
changing a due, fee, or other charge imposed by a self-regulatory
organization pursuant to Section 19(b)(3)(A) of the Act,\4\ and Rule
19b-4(f)(2) thereunder,\5\ which renders the proposal effective upon
filing with the Commission. The Commission is publishing this notice to
solicit comments on the proposed rule change, as amended, from
interested persons.
---------------------------------------------------------------------------
\1\ 15 U.S.C. 78s(b)(1).
\2\ 17 CFR 240.19b-4.
\3\ In Amendment No. 1, the Exchange made non-substantive
changes to re-format a defined term and clarify the addition of
disclaimer language in its $60,000 ``Firm Related'' Equity Option
and Index Option Cap schedule. The effective date of the original
proposed rule change is June 7, 2005, and the effective date of
Amendment No. 1 is July 5, 2005. For purposes of calculating the 60-
day period within which the Commission may summarily abrogate the
proposed rule change, as amended, under Section 19(b)(3)(C) of the
Act, the Commission considers such period to commence on July 5,
2005, the date on which the Exchange filed Amendment No. 1. See 15
U.S.C. 78s(b)(3)(C).
\4\ 15 U.S.C. 78s(b)(3)(A).
\5\ 17 CFR 240.19b-4(f)(2).
---------------------------------------------------------------------------
I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change
The Phlx proposes to amend its schedule of fees to adopt a license
fee of $0.10 for options traded on the following products: \6\ (1)
iShares S&P 100 Index, traded under the symbol OEF; (2) iShares S&P
Europe 350, traded under the symbol IEV; (3) iShares S&P Global 100
Index, traded under the symbol IOO; (4) iShares S&P Global Energy
Sector Index, traded under the symbol IXC; (5) iShares S&P Global
Financial Sector Index, traded under the symbol IXG; (6) iShares S&P
Global Healthcare Sector Index, traded under the symbol IXJ; (7)
iShares S&P Global Information Technology Sector Index, traded under
the symbol IXN; (8) iShares S&P Global Telecom Sector Index, traded
under the symbol IXP; (9) iShares S&P Latin America 40, traded under
the symbol ILF; (10) iShares S&P MidCap 400, traded under the symbol
IJH; (11) iShares S&P SmallCap 600, traded under the symbol IJR; (12)
iShares S&P TOPIX 150, traded under the symbol ITF; (13) iShares S&P
500, traded under the symbol IVV; (14) S&P Industrial Select Sector
SPDR, traded under the symbol XLI; (15) S&P Technology Select Sector
SPDR, traded under the symbol XLK; (16) S&P Utilities Select Sector
SPDR, traded under the symbol XLU; (17) S&P Consumer Staples Select
Sector SPDR, traded under the symbol XLP; (18) S&P Energy Select Sector
SPDR, traded under the symbol XLE; (19) S&P Financial Select Sector
SPDR, traded under the symbol XLF; (20) S&P Health Care Select Sector
SPDR, traded under the symbol XLV; (21) S&P Materials Select Sector
SPDR, traded under the symbol XLB; (22) S&P Consumer Discretionary
Select Sector SPDR, traded under the symbol XLY; (23) MidCap SPDR,
traded under the symbol MDY (collectively, the ``S&P products''); and
(24) WellSpring Bio-Clinical Trials
[[Page 42612]]
Index (``WHC'') \7\ to be assessed per contract side for equity option
and index option ``firm'' transactions (comprised of equity option
firm/proprietary comparison transactions, equity option firm/
proprietary transactions, equity option firm/proprietary facilitation
transactions, index option firm/proprietary comparison transactions,
index option firm/proprietary transactions and index option firm/
proprietary facilitation transactions). This license fee will be
imposed only after the Exchange's $60,000 ``firm-related'' equity
option and index option comparison and transaction charge cap,
described more fully below, is reached.
---------------------------------------------------------------------------
\6\ The Exchange represents that this fee will be charged only
to Exchange members. Telephone conversation between Cynthia
Hoekstra, Director, Phlx, and Edward Cho, Attorney, Division of
Market Regulation (``Division''), Commission (July 7, 2005).
\7\ WellSpring Bio-Clinical Trials Index, ``ORCHIDs'' and
``WellSpring'' are trademarks of WellSpring BioCapital Partners, LLC
(``WellSpring LLC'') and have been licensed for use by the Exchange.
WellSpring LLC makes no recommendations concerning the advisability
of investing in options based on the WellSpring Bio-Clinical Trials
Index.
---------------------------------------------------------------------------
Currently, the Exchange imposes a cap of $60,000 per member
organization \8\ on all ``firm-related'' equity option and index option
comparison and transaction charges combined.\9\ Specifically, ``firm-
related'' charges include equity option firm/proprietary comparison
charges, equity option firm/proprietary transaction charges, equity
option firm/proprietary facilitation transaction charges, index option
firm/proprietary comparison charges, index option firm/proprietary
transaction charges, and index option firm/proprietary facilitation
transaction charges (collectively, the ``firm-related charges''). Thus,
such firm-related charges in the aggregate for one billing month may
not exceed $60,000 per month per member organization.
---------------------------------------------------------------------------
\8\ The firm/proprietary comparison or transaction charge
applies to member organizations for orders for the proprietary
account of any member or non-member broker-dealer that derives more
than 35% of its annual, gross revenues from commissions and
principal transactions with customers. Member organizations are
required to verify this amount to the Exchange by certifying that
they have reached this threshold by submitting a copy of their
annual report, which was prepared in accordance with Generally
Accepted Accounting Principles (``GAAP''). In the event that a
member organization has not been in business for one year, the most
recent quarterly reports, prepared in accordance with GAAP, are
accepted. See Securities Exchange Act Release No. 43558 (November
14, 2000), 65 FR 69984 (November 21, 2000) (SR-Phlx-2000-85).
\9\ See Securities Exchange Act Release No. 51024 (January 11,
2005), 70 FR 3088 (January 19, 2005) (SR-Phlx-2004-94).
---------------------------------------------------------------------------
The Exchange also imposes a license fee of $0.10 per contract side
for equity option ``firm'' transactions on options on Nasdaq-100 Index
Tracking StockSM \10\ traded under the symbol QQQQ (``QQQ'')
and certain other licensed products (collectively, the ``licensed
products'') \11\ after the $60,000 cap, as described above, is reached.
Therefore, when a member organization exceeds the $60,000 cap
(comprised of combined firm-related charges), the member organization
is charged $60,000, plus license fees of $0.10 per contract side for
any contracts in licensed products (if any) over those that were
included in reaching the $60,000 cap. In other words, if the cap is
reached, the $0.10 license fee is imposed on all subsequent equity
option and index option firm transactions; these license fees are
charged in addition to the $60,000 cap.
The Exchange proposes to adopt a $0.10 license fee per contract
side for the S&P products and WHC for equity option and index option
firm transactions, which will be imposed after the $60,000 cap is
reached in the same way as the current licensed product fees are
assessed. Thus, when a member organization exceeds the $60,000 cap, the
member organization will be charged $60,000 plus any applicable license
fees for trades of licensed products, including the S&P products and
WHC, over those trades that were counted in reaching the $60,000
cap.\12\
---------------------------------------------------------------------------
\10\ The Nasdaq-100[supreg], Nasdaq-100 Index[supreg],
Nasdaq[supreg], The Nasdaq Stock Market[supreg], Nasdaq-100
SharesSM, Nasdaq-100 TrustSM, Nasdaq-100 Index
Tracking StockSM, and QQQSM are trademarks or
service marks of The Nasdaq Stock Market, Inc. (``Nasdaq'') and have
been licensed for use for certain purposes by the Phlx pursuant to a
License Agreement with Nasdaq. The Nasdaq-100 Index[supreg] (the
``Index'') is determined, composed, and calculated by Nasdaq without
regard to the Licensee, the Nasdaq-100 TrustSM, or the
beneficial owners of Nasdaq-100 SharesSM. Nasdaq has
complete control and sole discretion in determining, comprising, or
calculating the Index or in modifying in any way its method for
determining, comprising, or calculating the Index in the future.
\11\ In addition to the QQQs, the following licensed products
are assessed a $0.10 license fee per contract side after the $60,000
cap is reached: Russell 1000 Growth iShares (IWF); Russell 2000
iShares (IWM); Russell 2000 Value iShares (IWN); Russell 2000 Growth
iShares (IWO); Russell Midcap Growth iShares (IWP); Russell Midcap
Value iShares (IWS); NYSE Composite Index (NYC); NYSE U.S. 100 Index
(NY); and Standard & Poor's Depositary Receipts[supreg], Trust
Series 1 (SPY); iShares Lehman 1-3 Year Treasury Bond Fund (SHY);
iShares Lehman 7-10 Year Treasury Bond Fund (IEF); iShares Lehman
20+ Treasury Bond Fund (TLT); iShares Lehman Aggregate Bond Fund
(AGG); iShares Lehman TIPS Bond Fund (TIP); KBW Capital Markets
Index (KSX); KBW Insurance Index (KIX); and Phlx/KBW Bank Index
(BKX).
\12\ Consistent with current practice, when calculating the
$60,000 cap, the Exchange first calculates all equity option and
index option transaction and comparison charges for products without
license fees and then equity option and index option transaction and
comparison charges for products with license fees (i.e., QQQ license
fees) that are assessed by the Exchange after the $60,000 cap is
reached. See Securities Exchange Act Release No. 50836 (December 10,
2004), 69 FR 75584 (December 17, 2004) (SR-Phlx-2004-70).
---------------------------------------------------------------------------
In addition, the Exchange proposes to make a technical change to
its Summary of Index Option and FXI Options Charges (``Options Charge
Schedule'') to make a footnote, which relates to the $60,000 cap and
appears in other applicable sections of the Exchange's fee schedule,
more consistent.\13\ The Exchange also proposes to include non-
substantive disclaimer language relating to the trading of certain
licensed products on the Exchange in its $60,000 ``Firm Related''
Equity Option and Index Option Cap schedule (``$60,000 Cap
Schedule'').\14\ The fees set forth in this proposal are scheduled to
become effective for transactions settling on or after June 8, 2005.
---------------------------------------------------------------------------
\13\ Telephone conversation between Cynthia Hoekstra, Director,
Phlx, and Edward Cho, Attorney, Division, Commission (July 7, 2005).
\14\ Id.
---------------------------------------------------------------------------
The text of the proposed rule change is available on the Phlx's
Internet Web site (https://www.phlx.com), at the Phlx's Office of the
Secretary, and at the Commission's Public Reference Room.
II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change
In its filing with the Commission, the Phlx included statements
concerning the purpose of and basis for the proposed rule change and
discussed any comments it received on the proposal. The text of these
statements may be examined at the places specified in Item IV below.
The Exchange has prepared summaries, set forth in sections A, B, and C
below, of the most significant aspects of such statements.
A. Self-Regulatory Organization's Statement of the Purpose of, and the
Statutory Basis for, the Proposed Rule Change
1. Purpose
The purpose of assessing the S&P products and WHC license fee of
$0.10 per contract side after reaching the $60,000 cap as described in
this proposal is to help defray licensing costs associated with the
trading of these products, while still capping member organizations'
fees enough to attract volume from other exchanges. The cap operates
this way in order to offer an incentive for additional volume without
leaving the Exchange with significant out-of-pocket costs.
The purpose of making minor technical changes to the Exchange's
Options Charge Schedule is to make a footnote, which relates to the
$60,000
[[Page 42613]]
cap and appears in other applicable sections of the Exchange's fee
schedule, more consistent. In addition, the Exchange proposes to
include non-substantive disclaimer language relating to the trading of
certain licensed products on the Exchange in its $60,000 Cap Schedule.
2. Statutory Basis
The Exchange believes that the proposed rule change, as amended, is
consistent with Section 6(b) of the Act \15\ in general, and furthers
the objectives of Section 6(b)(4) of the Act \16\ in particular, in
that it is an equitable allocation of reasonable dues, fees, and other
charges among Exchange members.
---------------------------------------------------------------------------
\15\ 15 U.S.C. 78f(b).
\16\ 15 U.S.C. 78f(b)(4).
---------------------------------------------------------------------------
B. Self-Regulatory Organization's Statement on Burden on Competition
The Phlx believes that the proposed rule change would impose no
burden on competition that is not necessary or appropriate in
furtherance of the purposes of the Act.
C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants or Others
The Exchange did not solicit or receive any written comments with
respect to the proposal.
III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action
The foregoing proposed rule change, as amended, has been designated
as a fee change pursuant to Section 19(b)(3)(A)(ii) of the Act \17\ and
Rule 19b-4(f)(2) \18\ thereunder. Accordingly, the proposal is
effective upon filing with the Commission. At any time within 60 days
of the filing of the amended proposed rule change, the Commission may
summarily abrogate such rule change if it appears to the Commission
that such action is necessary or appropriate in the public interest,
for the protection of investors, or otherwise in furtherance of the
purposes of the Act.\19\
---------------------------------------------------------------------------
\17\ 15 U.S.C. 78s(b)(3)(A)(ii).
\18\ 17 CFR 240.19b-4(f)(2).
\19\ See supra note 3.
---------------------------------------------------------------------------
IV. Solicitation of Comments
Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change, as amended, is consistent with the Act. Comments may be
submitted by any of the following methods:
Electronic Comments
Use the Commission's Internet comment form (https://
www.sec.gov/rules/sro.shtml); or
Send an e-mail to rule-comments@sec.gov. Please include
File Number SR-Phlx-2005-40 on the subject line.
Paper Comments
Send paper comments in triplicate to Jonathan G. Katz,
Secretary, Securities and Exchange Commission, Station Place, 100 F
Street NE., Washington, DC 20549-9303.
All submissions should refer to File Number SR-Phlx-2005-40. This
file number should be included on the subject line if e-mail is used.
To help the Commission process and review your comments more
efficiently, please use only one method. The Commission will post all
comments on the Commission's Internet Web site (https://www.sec.gov/
rules/sro.shtml). Copies of the submission, all subsequent amendments,
all written statements with respect to the proposed rule change that
are filed with the Commission, and all written communications relating
to the proposed rule change between the Commission and any person,
other than those that may be withheld from the public in accordance
with the provisions of 5 U.S.C. 552, will be available for inspection
and copying in the Commission's Public Reference Room. Copies of such
filing also will be available for inspection and copying at the
principal office of the Exchange. All comments received will be posted
without change; the Commission does not edit personal identifying
information from submissions. You should submit only information that
you wish to make available publicly. All submissions should refer to
File Number SR-Phlx-2005-40 and should be submitted on or before August
15, 2005.
For the Commission, by the Division of Market Regulation,
pursuant to delegated authority.\20\
---------------------------------------------------------------------------
\20\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------
Jill M. Peterson,
Assistant Secretary.
[FR Doc. E5-3945 Filed 7-22-05; 8:45 am]
BILLING CODE 8010-01-P